These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25728635)

  • 1. Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels.
    Liu M; Yao XD; Li W; Geng J; Yan Y; Che JP; Xu YF; Zheng JH
    Biofactors; 2015; 41(1):52-7. PubMed ID: 25728635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells.
    Khurana N; Talwar S; Chandra PK; Sharma P; Abdel-Mageed AB; Mondal D; Sikka SC
    Int J Oncol; 2016 Oct; 49(4):1609-19. PubMed ID: 27499349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
    Shiota M; Yokomizo A; Naito S
    Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation.
    Zhang C; Su ZY; Khor TO; Shu L; Kong AN
    Biochem Pharmacol; 2013 May; 85(9):1398-404. PubMed ID: 23416117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacodynamics of indole-3-carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: involvement of Nrf2 and cell cycle/apoptosis signaling pathways.
    Wu TY; Saw CL; Khor TO; Pung D; Boyanapalli SS; Kong AN
    Mol Carcinog; 2012 Oct; 51(10):761-70. PubMed ID: 21837756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
    Nair S; Barve A; Khor TO; Shen GX; Lin W; Chan JY; Cai L; Kong AN
    Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
    Singh KB; Kim SH; Hahm ER; Pore SK; Jacobs BL; Singh SV
    Carcinogenesis; 2018 May; 39(6):826-837. PubMed ID: 29668854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling.
    Chen X; Jiang Z; Zhou C; Chen K; Li X; Wang Z; Wu Z; Ma J; Ma Q; Duan W
    Cell Physiol Biochem; 2018; 50(3):1201-1215. PubMed ID: 30355942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.
    Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M
    Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.
    Lee SO; Ma Z; Yeh CR; Luo J; Lin TH; Lai KP; Yamashita S; Liang L; Tian J; Li L; Jiang Q; Huang CK; Niu Y; Yeh S; Chang C
    J Mol Cell Biol; 2013 Feb; 5(1):14-26. PubMed ID: 22831834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulforaphane Protect Against Cadmium-Induced Oxidative Damage in mouse Leydigs Cells by Activating Nrf2/ARE Signaling Pathway.
    Yang SH; Li P; Yu LH; Li L; Long M; Liu MD; He JB
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
    Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW
    Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
    O'Reilly D; Downing T; Kouba S; Potier-Cartereau M; McKenna DJ; Vandier C; Buchanan PJ
    Cell Calcium; 2022 May; 103():102554. PubMed ID: 35193095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer.
    Guo C; Yeh S; Niu Y; Li G; Zheng J; Li L; Chang C
    Cancer Lett; 2017 Jul; 397():133-143. PubMed ID: 28323036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells.
    Schultz MA; Hagan SS; Datta A; Zhang Y; Freeman ML; Sikka SC; Abdel-Mageed AB; Mondal D
    PLoS One; 2014; 9(1):e87204. PubMed ID: 24466341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression.
    Yang W; Wang K; Ma J; Hui K; Lv W; Ma Z; Huan M; Luo L; Wang X; Li L; Chen Y
    Arch Med Res; 2021 Feb; 52(2):174-181. PubMed ID: 33059953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression.
    Chou FJ; Chen Y; Chen D; Niu Y; Li G; Keng P; Yeh S; Chang C
    EBioMedicine; 2019 Feb; 40():504-516. PubMed ID: 30692044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary tomato and lycopene impact androgen signaling- and carcinogenesis-related gene expression during early TRAMP prostate carcinogenesis.
    Wan L; Tan HL; Thomas-Ahner JM; Pearl DK; Erdman JW; Moran NE; Clinton SK
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1228-39. PubMed ID: 25315431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane suppresses carcinogenesis of colorectal cancer through the ERK/Nrf2‑UDP glucuronosyltransferase 1A metabolic axis activation.
    Hao Q; Wang M; Sun NX; Zhu C; Lin YM; Li C; Liu F; Zhu WW
    Oncol Rep; 2020 Apr; 43(4):1067-1080. PubMed ID: 32323779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.